Company Research Report: Endostart s.r.l.

Company Overview

• Name: Endostart s.r.l.

• Mission: To enhance gastrointestinal endoscopes, enabling effective, safer, faster, and easier diagnostic and therapeutic endoscopic procedures in patients with challenging cases. The company aims to bring sustainable solutions that are available, affordable, and accessible worldwide. Their Magnetic Balloon Technology is designed to enhance the tools available to endoscopists, raising the quality of care for all patients.

• Founded: 2018

• Founders: Alessandro Tozzi, MD, and Alberto Bruni

• Key People:

• Alessandro Tozzi, MD - Cofounder and CEO

• Alberto Bruni - Cofounder and Special Attorney

• Roberto Ghidini - CTO

• Alessandra Marsano - Sales and Marketing Director - Europe

• Andrew Amiel - VP of Business Development

• Flavio Venturi - CFO

• Letizia Giannini - Administration and Accounting Manager

• Denise Lazzeri - Quality Assurance and Regulatory Affairs Manager

• Headquarters: Via delle Regioni, 265, 50052 Certaldo, Toscana, Italy

• Number of Employees: 11-50 employees

• Revenue: No information is available

• Known For: Development and manufacturing of innovative medical devices for gastrointestinal endoscopy, particularly using Magnetic Balloon Technology to enhance endoscopic procedures.

Products

Endorail® System

• Description: A system designed to improve endoscopic procedures by resolving loop challenges that can hinder precise endoscope movements, particularly in colonoscopy and enteroscopy.

• Key Features:

• Magnetic Balloon Technology: Enhances control of endoscope and aids in solving loops which can otherwise prolong or complicate procedures.

• Endorail Balloon Guide: A disposable balloon catheter that can be inserted into the endoscope tool channel and filled with biocompatible Ferromagnetic Fluid.

• Endorail Handpiece: Contains a permanent magnet that allows modulation of the magnetic field to stabilize the balloon.

• Endorail Cart: Provides a compact storage solution for the Endorail Handpiece, readily accessible in endoscopic rooms.

Recent Developments

• CE Marking for Endorail®: As of October 11, 2024, Endostart secured CE marking for Endorail®, expanding its application from colonoscopy to enteroscopy, thus making complex procedures more accessible.

• FDA 510(k) Clearance: On March 26, 2024, Endostart received FDA 510(k) clearance for Endorail®, marking a new era of innovation in gastrointestinal endoscopy.

• Appointment: On July 15, 2022, Christopher Rowland was appointed the Chairman of the company’s Board of Directors.

• Partnerships: HC21 has partnered with Endostart to promote the Endorail® System as a breakthrough in colonoscopy technology.

Scientific Contributions

• Scientific Papers: Endostart's Magnetic Balloon-Assisted Colonoscopy has been the subject of numerous research studies and trials, indicating promising results in improving colonoscopy completion rates and efficiency. These studies have been published in notable journals such as Gastrojournal, Endoscopy Journal, and Digestive and Liver Disease Journal.

Company Achievements

• Investor Support: Endostart is backed by private investors and led by a highly professional team with an international Board of Directors.

• Quality Management: The company implements a comprehensive quality management system according to ISO 13485 standards.

Core Values

• Innovation: Forward-thinking approach that constantly seeks to expand horizons.

• Usability: Designing products that are easy to adopt and overcome daily challenges in endoscopic procedures.

• Integrity: Building trust and loyalty within the business community.

• Passion: Commitment to quality and enthusiasm for success.

• Teamwork: Collaboration is vital, as the whole is greater than the sum of its parts.

• Sustainability: Commitment to social and environmental sustainability.

Please note that all information is based on available data and is subject to updates as new developments occur.